About us

Lawarence press is an information solution company’s endeavour to bring information among research professionals of the health, science and technology sectors.
We publish contents with the mission to provide information which is universally accessible. We provide easily accessible and elegant online publishing solutions.
Our mission is to empower research work providing web-based digital publishing platform solutions of an international standard. .
Our company vision is to provide the highest standard in an online publishing platform.
We value innovation, originality & quality.

European Wellness – The Evidenced Rationale behind the Biological Medicine: Ad Astra Per Aspera

Dmitry Klokol, Mike K.S. Chan, Michelle B.F. Wong

Abstract


Modern conventional healthcare system is not always able to provide “wellness” and well-being to the patients. This became a growing concern in the society that resulted in increased interest of the public to alternative medicine. The paper provides a critical analysis to the current situation of alternative medicine and offers a promising solution in a form of Biological Wellness – a global concept created and provided by the European Wellness Centers.

Keywords


wellness, biological medicine, biological wellness, alternative medicine, treatment paradigms, rejuvenation

Full Text:

References


Eisenberg DM, Davis RD, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997 results of a follow-up national survey. JAMA. 1998, 280(18):1569–1575.

Thomas K, Coleman P. Use of complementary or alternative medicine in a general population in Great Britain. Results from the National Omnibus survey. J Public Health. 2004;26:152–157.

Ernst E. Prevalence of use of complementary/alternative medicine: a systematic review. Bull World Health Organ.2000;78:252–257.

MacLennan AH, Wilson DH, Taylor AW. Prevalence and cost of alternative medicine in Australia. Lancet. 1996;347:569–573.

Hung A, Kang N, Bollom A, Wolf JL, Lembo A. Complementary and alternative medicine use is prevalent among patients with gastrointestinal diseases. Dig Dis Sci. 2015;60:1883–1888.

Peltzer K, Pengpid S. Prevalence and determinants of traditional, complementary and alternative medicine provider use among adults from 32 countries. Chin J Integr Med. 2016 Dec 27.

O’Connor NA, Graham DM, McCaffrey J, Carney DN. The use of complementary and alternative medicine (CAM) by Irish patients with cancer. J ClinOncol. 2011 May 20;29, suppl.

TibanaSamano ES, Del Giglio A, Ribeiro LM, et al. Use of complementary/alternative medicine by Brazilian oncologists. J ClinOncol. 2004 Jul 15;22, suppl.

Loquai C, Dechent D, Garzarolli M, Kaatz M, Kaehler KC, Kurschat P, et al. Use of complementary and alternative medicine: A multicenter cross-sectional study in 1089 melanoma patients.Eur J Cancer. 2017;71:70–79.

Chan M, Wong M, Teppone M, Tukhvatullina D, Klokol D. Efficacy of renal precursor stem cells in management of chronic kidney disease: a cohort study. J Scien Res and Studies. 2016;3:119–125.

Chan M, Wong M, Beguine A, Teppone M, Tukhvatullina D, Klokol D. Efficacy of the MFIII placenta extracts softgels supplementation: a randomized double-blind placebocontrolled study. Basic Res J Med ClinScienc. 2016. 5:86–95.

Klokol D, Chan M, Wong M, et al. Application of cell extracts from skin, placenta, mesenchyme with collagen and elastin in aesthetic dermatology and skin revitalization: evaluation of outcomes in cohort study. Am J Avd Drud Deliv. 2016;4:69-77.

Klokol D. Mitochondrial specific peptides in anti-aging and therapeutic rejuvenation: An innovative fusion of mitochondrial medicine and cellular therapy. Aesteth Dermatol and Surg. 2016, 5-CC, Spain:35–36.

Klokol D, Teppone M. Management of metastatic colorectal carcinoma with GcMAF forte and thymus peptides. J Clin Cell Immunol 2016;7:4.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2017 Journal of Pharmaceutical and Biomedical Sciences

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.